Curated metabolic health research from PubMed and leading YouTube channels
Subscribe via RSSShowing 1-12 of 100 articles
Gut microbiota-modulating interventions may enhance glycemic control in children with type 1 diabetes, particularly in reducing HbA1c and fasting glucose levels.
This study highlights the role of systemic inflammatory indices in identifying diabetic macular edema, emphasizing the importance of monitoring these biomarkers for metabolic health.
Extra-coronary calcification (ECC) may serve as a crucial cardiovascular risk marker for women, particularly those overlooked by traditional assessments.
This study reveals that epicardial fat volume is significantly higher in spondyloarthritis patients, linking it to increased cardiovascular risk and inflammation.
Liver aging is linked to metabolic diseases, driven by epigenetic loss and circadian disruption. Understanding these mechanisms can guide lifestyle interventions for better health.
Recent research reveals that mu opioid receptors in the pancreas influence glucose metabolism and ingestive behaviors, particularly in males, highlighting new avenues for metabolic health.
A recent study reveals how interferon responses in COVID-19 patients impact metabolic health, highlighting the connection between inflammation and lipid metabolism.
This study identifies DNA methylation markers that can predict weight loss success in children with obesity, paving the way for personalized interventions.
This study reveals that coronary artery calcification is linked to increased cardiovascular events in patients with advanced lung cancer, highlighting the need for careful monitoring.
This study reveals how specific dietary patterns influence insulin resistance, particularly in the liver, highlighting the importance of diet in managing type 2 diabetes risk.
Combining tirzepatide with intermittent cold exposure may enhance metabolic health by reducing food intake and improving glucose homeostasis without weight loss.
New research reveals how lipogenesis-driven EGFR palmitoylation aids immune evasion in TNBC, suggesting FASN inhibitors could enhance anti-tumor immunity.